Pharmacological content of hyperproteolytic states in blood by synthetic inhibitors of serine proteinases.
Proteolytic enzymes participate extensively in coagulation, fibrinolysis, kininogenesis, and complement activity. Synthetic low molecular weight inhibitors of these enzymes which belong to the group of serine proteinases allow pharmacological control of these processes. The development of such inhibitors and their therapeutic importance are reported, especially on the pattern of benzamidine derivatives.
D001777:Blood Coagulation; D003169:Complement Inactivator Proteins; D005342:Fibrinolysis; D006801:Humans; D007705:Kinins / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors; D012694:Serine / Q000037:antagonists & inhibitors*
D003169:Complement Inactivator Proteins; D007705:Kinins; D011480:Protease Inhibitors; D012694:Serine